阿德莱克斯
ARDX
3.09
-0.18
-5.50%
阿德莱克斯
US · ARDX
#3380 按市值排名
3.09
-0.18
-5.50%
实时 - 追踪5344个代码 - 心跳于313秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期（2026/Q3）披露持股的机构数量增加了1家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 72.60% +0.05pp
- 机构数量
- 290 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund45.51%
Hedge Fund21.45%
Individual/Insider3.38%
Public Company2.95%
Insurance Company1.07%
Private Company1.06%
Government Pension Fund0.39%
Family Office/Trust0.16%
Other24.02%
主要股东 截至 2026-06-30
BlackRock
9.43% · 23.50M 股
Rubric Capital Management LP
6.50% · 16.20M 股
Millennium Management LLC
5.58% · 13.90M 股
State Street Global Advisors
5.36% · 13.36M 股
Vanguard Capital Management, LLC
4.91% · 12.23M 股
Macquarie Investment Management Business Trust
3.83% · 9.55M 股
Vanguard Portfolio Management, LLC
3.22% · 8.03M 股
Geode Capital Management, LLC
2.57% · 6.40M 股
Janus Henderson Group plc
2.13% · 5.30M 股
Two Sigma Investments, LP
2.09% · 5.21M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 16次买入 · 32次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| David Mott | Independent Chairperson | 1.33% |
| Michael Raab | Chief Executive Officer | 0.66% |
| Eric Foster | Chief Commercial Officer | 0.16% |
| Richard Rodgers | Independent Director | 0.16% |
| Laura Williams | Chief Medical Officer | 0.15% |
| Mike Kelliher | Executive Vice President of Corporate Development & Strategy | 0.14% |
| John Bishop | -- | 0.13% |
| William Charles Bertrand | Independent Director | 0.12% |
| Justin Renz | Chief Financial & Operations Officer and Treasurer | 0.10% |
| James Brady | Chief Human Resources Officer | 0.10% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-20 | Michael Raab | Chief Executive Officer | Private Disposition | -58,574 | $3.86 |
| 2026-08-20 | John Bishop | -- | Private Disposition | -19,750 | $3.86 |
| 2026-08-20 | James Brady | Chief Human Resources Officer | Private Disposition | -15,136 | $3.86 |
| 2026-08-20 | Laura Williams | Chief Medical Officer | Private Disposition | -10,739 | $3.86 |
| 2026-08-20 | Eric Foster | Chief Commercial Officer | Private Disposition | -8,562 | $3.86 |
| 2026-08-20 | Mike Kelliher | Executive Vice President of Corporate Development & Strategy | Private Disposition | -7,758 | $3.86 |
| 2026-08-20 | Joseph Reilly | Senior VP of Finance & Principal Accounting Officer | Private Disposition | -3,982 | $3.86 |
| 2026-08-20 | Sue Hohenleitner | Chief Financial Officer | Private Disposition | -1,558 | $3.86 |
| 2026-07-14 | Michael Raab | Chief Executive Officer | Automatic Disposition | -20,834 | $5.06 |
| 2026-07-14 | Michael Raab | Chief Executive Officer | Derivative Exercise and Sale | -20,834 | $0.99–5.06 |
| 2026-06-17 | Laura Williams | Chief Medical Officer | Automatic Disposition | -50,898 | $5.99 |
| 2026-06-17 | Laura Williams | Chief Medical Officer | Derivative Exercise and Sale | -31,000 | $0.99–5.99 |
| 2026-06-15 | David Mott | Independent Chairperson | Other Acquisition | +20,282 | -- |
| 2026-06-15 | David Mott | Independent Chairperson | Other Acquisition | +26,455 | -- |
| 2026-06-15 | David Mott | Independent Chairperson | Other Derivative Acquisition | +39,715 | $5.67 |
| 2026-06-15 | Robert Bazemore | Independent Director | Other Acquisition | +26,455 | -- |
| 2026-06-15 | Robert Bazemore | Independent Director | Other Derivative Acquisition | +39,715 | $5.67 |
| 2026-06-15 | William Charles Bertrand | Independent Director | Other Acquisition | +12,345 | -- |
| 2026-06-15 | William Charles Bertrand | Independent Director | Other Acquisition | +26,455 | -- |
| 2026-06-15 | William Charles Bertrand | Independent Director | Other Derivative Acquisition | +39,715 | $5.67 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:13 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
阿德莱克斯 讨论区 0 条评论